Prof. Dr. med. Frank Gansauge
You can watch an interview with Prof. Dr. med. Frank Gansauge about new methods of dendritic cell therapy here.
Prof. Dr. med. Frank Gansauge is the Director of the LDG Laboratories Dr. Gansauge Berg, and the Head Physician of the Department of Oncology and Dendritic Cell Therapy at this clinic.
Prof. Gansauge graduated from the Faculty of Medicine at the University of Tuebingen (Germany), and he also trained in Cardiff (UK). After his work at the University Hospital Ulm and habilitation at the University of Ulm, the professor focused on immunology and cancer treatment. In 2001, he founded the LDG Laboratories Dr. Gansauge Berg.
The clinic's unique offer is LANEX-DC® dendritic cell immunotherapy for cancer. Prof. Gansauge is one of the most experienced specialists in the field of dendritic cell therapy worldwide. LANEX-DC® dendritic cell immunotherapy is an innovative last-line treatment. Dendritic cells can significantly prolong the lives of patients who have already undergone all standard treatments.
Prof. Gansauge is the author of more than 160 scientific publications and numerous book chapters. He has also repeatedly won prestigious awards, including the Fred Stephans Award and the Merkle Research Award. He is also a Visiting Professor at Liaoning University of Technology in China, a Visiting Professor at the Faculty of Medicine of the University of Belgrade in Serbia, and a Professor at Shanxi Medical University in China.
Place of work: LDG Laboratories Dr. Gansauge GmbH
Reviewed the following articles:
- Dendritic cell therapy in cancer treatment in Germany
- Lung cancer treatment with dendritic cells in Germany
- Prostate cancer treatment with dendritic cells in Germany
- Breast cancer treatment with dendritic cells in Germany
- Treatment of melanoma with dendritic cells in Germany
- Treatment of glioblastoma with dendritic cells in Germany
- Colon cancer treatment with dendritic cells in Germany
- Treatment of osteosarcoma with dendritic cells
- Active immune system at any age
- Germany offers dendritic cell-based immunotherapy for pancreatic cancer
- Dendritic cell therapy for psoriasis treatment
- How are dendritic cells changing rheumatoid arthritis treatment strategies?
- Cervical cancer treatment with dendritic cell therapy
- Treatment of soft tissue sarcoma with dendritic cells
- Dendritic cells: a possible key to treating ulcerative colitis
- Intratumoral immunotherapy
- Immunological treatments for Alzheimers disease
- Immunotherapy for metastatic melanoma according to the TIL protocol
- Glioblastoma immunotherapy: treatment of brain tumours in Germany
- Immunotherapy for melanoma in Germany
- Immunotherapy for colon cancer in Germany
- Immunotherapy for lung cancer in Germany
- Immunotherapy for breast cancer in Germany
- Immunotherapy treatment for bladder cancer in Germany
- Immunotherapy treatment for liver cancer in Germany
- Immunotherapy for prostate cancer in Germany
- Cancer Immunotherapy
- Cancer immunotherapy in Germany
- Immunotherapy treatment for lymphoma in Germany
- Immunotherapy treatment for leukemia in Germany
- Immunotherapy treatment for kidney cancer in Germany
- Individualized immunotherapy for malignant tumors using peptide-based vaccines
Scientific publications: